−3.1131USD
−9.29 MUSD
3.20 M
About Artelo Biosciences, Inc.
Sector
CEO
Gregory D. Gorgas
Headquarters
Solana Beach
Website
Employees (FY)
6
Founded
2011
FIGI
BBG00PH7GHW0
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
